Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 343

1.

Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.

Burdach S, van Kaick B, Laws HJ, Ahrens S, Haase R, Körholz D, Pape H, Dunst J, Kahn T, Willers R, Engel B, Dirksen U, Kramm C, Nürnberger W, Heyll A, Ladenstein R, Gadner H, Jürgens H, Go el U.

Ann Oncol. 2000 Nov;11(11):1451-62. Review.

2.

Radiotherapy and high-dose chemotherapy in advanced Ewing's tumors.

Pape H, Laws HJ, Burdach S, van Kaik B, Glag M, Gripp S, Wittkamp M, Jürgens H, Göbel U, Schmitt G.

Strahlenther Onkol. 1999 Oct;175(10):484-7.

PMID:
10554642
3.

High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.

Meyers PA, Krailo MD, Ladanyi M, Chan KW, Sailer SL, Dickman PS, Baker DL, Davis JH, Gerbing RB, Grovas A, Herzog CE, Lindsley KL, Liu-Mares W, Nachman JB, Sieger L, Wadman J, Gorlick RG.

J Clin Oncol. 2001 Jun 1;19(11):2812-20.

PMID:
11387352
4.

High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.

Burdach S, Meyer-Bahlburg A, Laws HJ, Haase R, van Kaik B, Metzner B, Wawer A, Finke R, Göbel U, Haerting J, Pape H, Gadner H, Dunst J, Juergens H.

J Clin Oncol. 2003 Aug 15;21(16):3072-8.

PMID:
12915596
5.

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.

Burdach S, Jürgens H, Peters C, Nürnberger W, Mauz-Körholz C, Körholz D, Paulussen M, Pape H, Dilloo D, Koscielniak E, et al.

J Clin Oncol. 1993 Aug;11(8):1482-8.

PMID:
8101562
6.

Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.

Paulussen M, Ahrens S, Burdach S, Craft A, Dockhorn-Dworniczak B, Dunst J, Fröhlich B, Winkelmann W, Zoubek A, Jürgens H.

Ann Oncol. 1998 Mar;9(3):275-81.

7.
8.

[High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS].

Fröhlich B, Ahrens S, Burdach S, Klingebiel T, Ladenstein R, Paulussen M, Zoubek A, Jürgens H.

Klin Padiatr. 1999 Jul-Aug;211(4):284-90. German.

PMID:
10472563
9.

Treatment of multiple myeloma.

San Miguel JF, Bladé Creixenti J, García-Sanz R.

Haematologica. 1999 Jan;84(1):36-58. Review.

10.

Relapse after high-dose therapy in relapsed Ewing's tumor patients: effects of maintenance chemotherapy in two selected patients?

Laws HJ, van Kaick B, Pape H, Paulussen M, Göbel U.

Onkologie. 2003 Dec;26(6):573-7.

PMID:
14709933
11.

Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center report.

Laws HJ, Burdach S, van Kaick B, Engel B, Dirksen U, Körholz D, Pape H, Kahn T, Merck H, Schmitz M, Heyll A, Dockhorn-Dworniczak B, Jürgens H, Göbel U.

Strahlenther Onkol. 1999 Oct;175(10):488-94.

PMID:
10554643
12.

Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.

Ozkaynak MF, Matthay K, Cairo M, Harris RE, Feig S, Reynolds CP, Buckley J, Villablanca JG, Seeger RC.

J Clin Oncol. 1998 Mar;16(3):937-44.

PMID:
9508176
13.

Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor.

Laurence V, Pierga JY, Barthier S, Babinet A, Alapetite C, Palangié T, de Pinieux G, Anract P, Pouillart P.

Am J Clin Oncol. 2005 Jun;28(3):301-9. Review.

PMID:
15923805
14.

Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.

Pérez-Simón JA, Caballero D, Diez-Campelo M, Lopez-Pérez R, Mateos G, Cañizo C, Vazquez L, Vidriales B, Mateos MV, Gonzalez M, San Miguel JF.

Leukemia. 2002 Aug;16(8):1423-31. Review.

15.

Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.

Berglund A, Enblad G, Carlson K, Glimelius B, Hagberg H.

Eur J Haematol. 2000 Jul;65(1):17-22.

PMID:
10914935
16.

Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.

Kobos R, Steinherz PG, Kernan NA, Prockop SE, Scaradavou A, Small TN, Shukla N, Khalaf R, O'Reilly RJ, Boulad F.

Biol Blood Marrow Transplant. 2012 Mar;18(3):473-80. doi: 10.1016/j.bbmt.2011.11.009.

17.
18.

Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.

Czyzewski EA, Goldman S, Mundt AJ, Nachman J, Rubin C, Hallahan DE.

Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):569-77.

PMID:
10348286
19.

Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?

Seyfarth B, Kuse R, Sonnen R, Glass B, Schmitz N, Dreger P.

Ann Hematol. 2001 Jul;80(7):398-405.

PMID:
11529465
20.

Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.

Avramova B, Jordanova M, Michailov G, Konstantinov D, Christosova I, Bobev D.

J BUON. 2006 Oct-Dec;11(4):433-8.

PMID:
17309174
Items per page

Supplemental Content

Support Center